# What Is Biostatistics? Methods, Examples and Careers

Biostatistics is the branch of statistics that designs, analyzes, and interprets data from biology, medicine, and public health. It converts observations about living systems into estimates that carry a stated margin of uncertainty, so that a decision can be defended with numbers rather than opinion.

Numbers decide things in medicine. A late-stage trial determines whether a drug reaches the market. A weekly case count determines whether an outbreak is described as growing or controlled. A screening protocol determines how many healthy people get called back for a second, more invasive test. Biostatistics supplies the methods required to design, analyze, interpret, and critically appraise clinical research, which is why it forms the foundation of evidence-based medicine [1]. Without those methods, a clinician reading a paper cannot separate a real treatment effect from noise, and a regulator has no defensible basis for approving or rejecting an application. The same logic applies to a lab comparing two assays, a hospital tracking infection rates, and a biotech team deciding whether to fund a confirmatory study.

## The Biostatistics Definition, Layer by Layer

A useful working definition has three parts, and they are hard to separate in practice.

**Design.** Before any data exist, a biostatistician decides what to measure, in whom, how often, and how many. This is where most of a study's validity is won or lost. A beautifully analyzed biased study is still a biased study.

**Analysis.** Once data exist, the job is to summarize them honestly and to quantify uncertainty. That means choosing a model that matches the data structure, checking whether the model's assumptions hold, and reporting estimates with [confidence intervals](/blog/data-analysis/confidence-interval-formula-examples) rather than bare p-values.

**Interpretation and communication.** A result has to be translated into a statement a clinician, regulator, or program manager can act on. This is the part that textbooks often underplay and employers value most. A practical review of biostatistics for clinicians makes the same point, noting that the emphasis belongs on the rationale behind [statistical methods](/blog/guides/statistical-methods) rather than on mathematical derivations, precisely so that clinicians can critically evaluate published studies and communicate effectively with statisticians [1].

### What makes a question biostatistical

A question is biostatistical when the answer depends on variation between living units. Patients differ in age, genetics, adherence, and comorbidity. Mice differ by litter. Batches of cells differ by passage number. Replicates differ because a pipette is not perfect. Biostatistics is the discipline that models that variation explicitly, rather than pretending it away.

The field is old enough to have a recognizable origin story. Eighteenth and nineteenth century physicians argued that medical claims should be tested against grouped outcomes rather than single dramatic cases, and John Snow's investigation of a London cholera outbreak in the 1850s is often cited as an early demonstration that counting by neighborhood could identify a waterborne source. Modern biostatistics grew alongside randomized trials, which made formal comparison possible, and then alongside computing, which made multivariable models routine.

## Biostatistics at a Glance

| Aspect | What it means |
|--|--|
| Core definition | The application of statistical design, estimation, and inference to biological, medical, and public health data |
| Three responsibilities | Design before data collection, analysis after it, interpretation for a decision-maker |
| Typical data sources | Randomized trials, cohort and case-control studies, cross-sectional surveys, disease surveillance, registries, electronic medical records, laboratory assays, sequencing and other omics data |
| Main method families | Descriptive statistics, estimation with confidence intervals, [hypothesis testing](/blog/data-analysis/what-is-hypothesis-testing), regression and multivariable modeling, survival analysis, diagnostic accuracy analysis, meta-analysis, Bayesian methods, machine learning |
| Primary outputs | Effect estimates, confidence intervals, p-values, risk and odds ratios, survival curves, adjusted predictions, sample size calculations |
| Closest sibling | General statistics uses the same mathematics on any data. Biostatistics applies it under biological and clinical constraints, including ethics, dropout, measurement error, and regulatory review |
| Neighboring field | Bioinformatics manages and processes molecular data at scale. Biostatistics quantifies uncertainty and supports inference from that data |
| Typical job title | Biostatistician, statistical programmer, statistical scientist, or a data scientist in a life science setting |
| Main employers | Pharmaceutical and biotechnology companies, contract research organizations, academic medical centers, schools of public health, government health agencies, diagnostics and genomics companies |

## Biostatistics vs Statistics: What Actually Differs

The mathematics is largely shared. A two-sample t-test is a two-sample t-test whether the observations are wheat yields or blood pressure readings. The difference is context, and context changes which methods are defensible.

**You cannot randomize everything.** No ethics committee will assign people to smoke for twenty years. Biostatistics therefore invests heavily in observational designs and in methods that try to approximate a randomized comparison, such as restriction, matching, stratification, regression adjustment, propensity scores, and instrumental variables. None of these fully replaces randomization, and knowing when the approximation is credible is a core skill.

**Human subjects drop out.** A trial that plans to follow 500 people for three years will lose some of them to relocation, withdrawal, or death from an unrelated cause. That produces censored observations, which is why survival analysis exists and why a naive average of follow-up time is misleading.

**Measurement is imperfect and sometimes biased.** A blood pressure reading depends on cuff size, body position, time of day, and whether the patient just drank coffee. A patient-reported pain score depends on mood and phrasing. A laboratory assay drifts between batches. Biostatisticians model measurement error, standardize collection, and run calibration checks, because a variable that is measured badly cannot be rescued by a clever model.

**Regulatory stakes change the process.** Studies submitted to support a medical product require a pre-specified [statistical analysis](/blog/guides/statistical-analysis) plan, documented programming, and an audit trail. Biostatisticians working in that environment write the plan before unblinding, so that a reasonable analysis cannot be swapped for a favorable one after the data are seen.

**Small samples and clustered structure are common.** A study may have 40 patients, or 12 litters of mice, or 3000 cells from 8 donors. Those structures demand mixed models, hierarchical models, or nonparametric tests. A generic statistics course may never touch them.

Biostatistics also differs from bioinformatics in emphasis. Bioinformatics builds and runs pipelines that align sequences, assemble genomes, quantify expression, and annotate variants. Biostatistics asks whether a difference between groups is larger than expected under a stated model. The two overlap in genomics, where a single project may need both a pipeline engineer and a statistician. Work on single-cell immune profiling illustrates the overlap, describing an intersection between genetics, engineering, computer science, biostatistics, and immunology that now supports characterization of immune cells at single-cell resolution in any organ or disease site [2].

## The Core Biostatistics Methods, in the Order a Study Uses Them

Methods are easiest to understand as a sequence, because each step constrains the next. The choice of a statistical model depends on study design, variable type, and data characteristics, which is why the analysis cannot be planned in isolation from the design [1].

### Step 1: State the question and the hypothesis

A testable question names a population, an exposure or intervention, a comparator, and an outcome. The null hypothesis is the default claim of no difference or no association. The [alternative hypothesis](/blog/data-analysis/alternative-hypothesis-definition-examples) is what the study is powered to detect. Vague questions such as "does exercise help health" cannot be tested. Specific ones can, for example "does a 12-week supervised walking program lower systolic blood pressure by at least 5 mmHg compared with usual care in adults aged 60 to 75 with treated hypertension."

### Step 2: Choose the design

The main designs are the randomized controlled trial, the [cohort study](/blog/guides/cohort-studies-a-practical-guide-to-design-conduct-and-interpretation), the case-control study, the cross-sectional survey, and the diagnostic accuracy study. Each has a natural measure of effect. Trials and cohorts usually estimate risk or rate ratios. Case-control studies estimate odds ratios. Cross-sectional studies estimate prevalence. Secondary analyses of registries and electronic medical records are increasingly common, since large linked datasets from medical records, insurance databases, biomarkers, imaging, and wearables are now accessible at scale [3].

### Step 3: Classify the variables

Every variable has a type, and the type determines the summary statistic and the model. Continuous variables (weight in kilograms, viral load in copies per milliliter) support means and linear models. Ordinal variables (pain rated mild, moderate, severe) support medians and rank-based tests. Nominal variables (blood type, treatment arm) support counts and contingency tables. Binary variables (alive or dead, responder or non-responder) support proportions and logistic models. Variables also have roles: outcome, exposure, confounder, effect modifier, and mediator. Confusing a confounder with an effect modifier is a common source of wrong conclusions.

### Step 4: Size the study

Sample size calculation balances four quantities: the effect size worth detecting, the variability of the outcome, the acceptable false positive rate (alpha), and the desired power. Power is the probability of detecting a real effect of that size. The conventional settings are a two-sided alpha of 0.05 and power of 0.80, though both should be justified rather than assumed.

For a two-arm comparison of means, the approximate sample size per group is 2 times (1.96 + 0.84) squared, divided by the squared standardized effect size. With a standardized effect of 0.5, that works out to roughly 63 per group, usually rounded up to 64. Halve the effect size and the required sample roughly quadruples, which is why modest real effects require large trials. For binary outcomes the calculation uses anticipated proportions instead of means, and the formula changes again for survival outcomes, where the number of events rather than the number of patients drives power.

### Step 5: Collect and organize data

Data organization is a method, not clerical work. A study needs a data dictionary that defines every field, its units, its allowed values, and its handling of missing entries. Double data entry and range checks catch transcription errors. An audit trail records every change. Unblinded interim looks are restricted to a small group, often an independent data safety monitoring board, because repeated looks at accumulating data inflate the false positive rate unless the alpha is spent according to a pre-specified plan.

### Step 6: Describe the data

Descriptive statistics summarize without claiming. Continuous, roughly symmetric variables get a mean and standard deviation. Skewed variables get a median and interquartile range. Categorical variables get counts and percentages. Two descriptive habits cause most errors.

The first is reporting a mean for a skewed variable. A biomarker where most values sit near 10 and a few reach 900 has a mean that describes almost nobody. The median is the better summary, and the mean should be reported alongside a note about skew.

The second is confusing the standard deviation with the standard error. The standard deviation describes how spread out the observations are. The standard error of the mean is the standard deviation divided by the square root of the sample size, and it describes how precisely the mean is estimated. With 100 observations the standard error is one tenth of the standard deviation. Plotting standard error bars instead of standard deviation bars makes a dataset look tighter than it is, and the two are not interchangeable.

Incidence and prevalence are also frequently mixed up. Prevalence is the proportion of a population with a condition at a point in time. Incidence is the rate of new cases over a period. A long-lasting mild condition can have high prevalence and low incidence. A rapidly fatal disease can have high incidence and low prevalence.

### Step 7: Estimate and test

Inferential statistics has two outputs that answer different questions. A confidence interval answers "how large could the effect be." A p-value answers "how surprising are these data if there is no effect."

A 95% confidence interval is constructed so that, if the study were repeated many times, 95% of the intervals built this way would contain the true value. It is not a 95% probability that the true value lies inside this particular interval, although that is the most common misreading. The interval's width communicates precision. A wide interval from a small study may include both a trivial harm and a large benefit, which is a genuinely inconclusive result.

A p-value is the probability of observing data at least as extreme as those collected, assuming the null hypothesis is true. It is not the probability that the null hypothesis is true, and it is not the probability that the result was due to chance. A small p-value says the data are unusual under the null model. It does not say the effect is large or important.

The standard tests follow from variable type. A two-sample t-test compares means in two independent groups. Analysis of variance compares means across three or more groups. A chi-square test compares proportions. McNemar's test handles paired binary data, such as the same patients tested before and after an intervention. Wilcoxon and Mann-Whitney tests compare distributions when normality is doubtful. The log-rank test compares survival curves.

Two error types matter. A Type I error is a false positive, declared when the null is true, and its long-run rate is alpha. A Type II error is a false negative, a real effect missed, and its complement is power. Lowering alpha to 0.01 reduces false positives but raises false negatives unless the sample grows.

Multiplicity is the hidden cost of testing many things. With 20 independent tests at alpha 0.05 and no real effects anywhere, the expected number of false positives is about 1, and the probability of at least one is roughly 64%. Multiplicity corrections such as the Bonferroni method, which divides alpha by the number of tests, control this at the price of reduced power. Pre-specifying a single primary endpoint is the cleaner solution.

### Step 8: Model the data

Regression extends the comparison to multiple variables at once. Linear regression models a continuous outcome. [Logistic regression](/blog/data-analysis/logistic-regression-definition-formula) models a binary outcome and reports odds ratios. Poisson and negative binomial regression model counts. Cox proportional hazards regression models time to an event.

The point of multivariable modeling is adjustment. An unadjusted comparison of two treatment groups may reflect an imbalance in age or disease severity rather than the treatment itself. Adjustment estimates the effect holding measured covariates constant. Model choice should follow the outcome type and the data structure, not habit [1].

Two cautions apply. First, overfitting: a model with many predictors and few events fits noise. A common rule of thumb is at least 10 events per predictor variable, which caps a study with 60 events at about six predictors. Second, odds ratios and risk ratios diverge when the outcome is common. If the risk is 20% in one group and 10% in another, the risk ratio is 2.0 while the odds ratio is 2.25. Reading an odds ratio as if it were a risk ratio exaggerates the effect.

### Step 9: Handle time to event

Survival analysis deals with censoring, the fact that some participants are still event-free when follow-up ends. Kaplan-Meier curves estimate the survival function, and the log-rank test compares curves. Cox models report a [hazard ratio](/blog/research-skills/hazard-ratio-explained), which is the relative instantaneous risk of the event at any given time. A hazard ratio of 0.75 means a 25% lower hazard at any moment, not a 25% longer survival time. Median survival, read off the curve where it crosses 50%, is often the more intuitive summary.

### Step 10: Check assumptions and report

Every model assumes something: independence of observations, constant variance, proportional hazards, linearity on the link scale. Residual plots, influence diagnostics, and sensitivity analyses test whether those assumptions hold. A result that survives several reasonable analytic choices is more credible than one that appears under a single specification. Reporting guidelines for trials and observational studies standardize what must be disclosed, including how participants were selected, how many were excluded, and which analyses were pre-specified.

## Biostatistics in Public Health

Public health is where biostatistics has the widest reach, because decisions apply to whole populations rather than to one patient.

**Surveillance.** Health departments track notifiable diseases, births, deaths, and hospitalizations. Raw counts mislead, so biostatisticians compute rates per 100,000 and age-standardize them, since a county with a large elderly population will show higher crude mortality for reasons that have nothing to do with local risk. Excess mortality compares observed deaths with an expected baseline, which is how the true toll of a crisis is estimated when reporting is incomplete.

**Outbreak investigation.** Epidemic curves, attack rates, and reproduction numbers describe transmission. Compartmental models such as the SIR framework, which divides a population into susceptible, infectious, and recovered groups, are standard tools for projecting spread and testing intervention scenarios [4]. These deterministic models sit alongside stochastic approaches including Monte Carlo simulation, Markov chains, and Bayesian networks, all of which appear in modern epidemiological and biological modeling [4].

**Vaccine and intervention trials.** Efficacy is usually reported as (1 minus the risk ratio) times 100. If disease incidence is 2% in a vaccinated group and 10% in [a control group](/blog/guides/understanding-control-groups-in-clinical-trials-types-and-selection), the risk ratio is 0.20 and efficacy is 80%. That number is a trial estimate for a defined population and time window, and it should not be read as a guarantee for an individual.

**Screening program evaluation.** Sensitivity, specificity, and predictive values determine whether a program does more good than harm. These are covered in the worked example below.

**Health equity analysis.** Stratifying outcomes by income, race, or geography, with confidence intervals attached, turns a general concern into a measurable gap. Combining large administrative datasets with clinical registries is one route, and the same data infrastructure that supports precision medicine also supports population monitoring [3].

## Biostatistics Examples

### Example 1: A two-arm clinical trial

A hypothetical trial randomizes 400 adults with type 2 diabetes to a new drug or placebo, 200 per arm, with change in HbA1c at 24 weeks as the primary endpoint. The statistical analysis plan fixes the primary comparison, the model (analysis of covariance adjusting for baseline HbA1c), the handling of missing data, and the alpha level. The result is a mean difference of minus 0.4 percentage points, 95% confidence interval minus 0.7 to minus 0.1, p = 0.01. The interval excludes zero, so the effect is statistically significant. The lower bound of 0.1 percentage points is smaller than most clinicians would consider meaningful, which is why the interval matters more than the p-value. A separate prespecified analysis checks whether the effect differs by baseline HbA1c, and that interaction test is reported as exploratory.

### Example 2: A screening test and the base rate trap

Assume a hypothetical screening test for a condition affecting 1% of a population of 10,000 people. The test has 95% sensitivity and 90% specificity. Of the 100 people with the condition, 95 test positive. Of the 9,900 without it, 10% test positive falsely, which is 990 people. Total positives are 1,085, of whom 95 are true positives. The positive predictive value is 95 divided by 1,085, or about 8.8%. Nine out of ten positives are false. This arithmetic is why screening programs for rare conditions need high specificity, and why confirmatory testing is mandatory. The same test applied in a high-prevalence clinic population would produce a far better positive predictive value, which is why predictive values do not travel between settings while sensitivity and specificity do.

### Example 3: An observational association with confounding

A cohort study from electronic health records finds that patients prescribed a statin have lower rates of a cardiovascular outcome. The unadjusted risk ratio is 0.70. But statin users are also more likely to be engaged with primary care, wealthier, and healthier at baseline, all of which lower risk independently. After adjustment for age, sex, diabetes, smoking, and prior events, the risk ratio moves to 0.85. The remaining association may still be partly confounded by unmeasured factors such as diet. This is why observational estimates are described as associations and why causal language requires additional assumptions.

### Example 4: High-dimensional laboratory data

A study profiles thousands of genes or epigenetic marks across tumor samples. The data are complex, high-dimensional, sparse, and noisy, which makes standard regression unstable [5]. Machine learning offers four broad families of methods for this setting: dimensionality reduction, unsupervised learning, supervised learning, and deep learning, each suited to different questions about hidden structure in the data [5]. Related work integrating multi-omic data shows the same pattern at a larger scale, where mathematical models and machine learning methods are combined to predict outcomes in complex diseases including diabetes, cancer, and neurodegenerative disorders [4]. The biostatistical contribution here is not the algorithm alone but the validation: held-out data, cross-validation, correction for multiple comparisons, and honest reporting of discrimination and calibration.

## How Biostatistical Work Is Checked in Practice

Biostatistics is a profession with its own quality controls, and knowing them helps when reading a paper or preparing for a job interview.

**Pre-specification.** The statistical analysis plan is written and dated before unblinding. Deviations are documented and labeled as post hoc. A result that appears only after the analysis was changed is a hypothesis, not a finding.

**Blinded review.** Programmers and statisticians review data quality and write analysis code while still blinded to treatment assignment where possible, which prevents unconscious bias in the choice of transformations or exclusions.

**Independent replication of the analysis.** In regulated settings, a second programmer independently reproduces the primary results. Any discrepancy is resolved before submission.

**Code and data review.** Reproducible analysis means the entire path from raw data to final table runs from a script under version control. Manual spreadsheet edits are the enemy of reproducibility.

**External review.** Data safety monitoring boards review interim results. Journal reviewers and regulators examine the analysis plan and the reported numbers for consistency.

**Reporting standards.** Consolidated reporting checklists for trials and observational studies require disclosure of participant flow, pre-specified outcomes, and the statistical methods used, which lets a reader judge whether the analysis was chosen before or after the data appeared.

## Careers: What a Biostatistician Does

A biostatistician is a statistician who works on biological, medical, or public health problems. The daily work is a mix of design consulting, programming, interpretation, and writing. The title covers a wide range, from an entry-level analyst producing tables to a principal statistician who owns the strategy for a regulatory submission.

### The work, week by week

**Design phase.** Sample size and power calculations, randomization schedules, endpoint definitions, and advice on how to reduce missing data. A statistician who is brought in after data collection can only mitigate problems, not prevent them, so experienced practitioners push to be involved at the protocol stage.

**Analysis phase.** Writing the statistical analysis plan, building and validating analysis datasets, writing programs in R or SAS, reviewing output, and interpreting results in plain language. Deliverables typically include tables, listings, and figures, plus the statistical sections of clinical study reports and manuscripts.

**Communication phase.** Explaining to a clinical team why a subgroup result is not reliable, presenting to a monitoring board, responding to a regulator's questions, or walking a reviewer through an analysis. Writing ability matters as much as mathematical ability here, because an analysis nobody understands cannot inform a decision.

### Where biostatisticians work

1. **Pharmaceutical and biotechnology companies.** Trial design, regulatory submissions, and post-marketing studies.
2. **Contract research organizations.** The same work delivered as a service to sponsors, often across many therapeutic areas at once.
3. **Academic medical centers and schools of public health.** Collaboration on grants, methodological research, and teaching.
4. **Government health agencies and regulatory bodies.** Surveillance, program evaluation, and review of product applications.
5. **Hospitals and health systems.** Quality measurement, readmission analysis, and clinical informatics.
6. **Diagnostics, genomics, and medical device companies.** Analytical validation, clinical validation, and algorithm performance reporting.

### Training path

A bachelor's degree in statistics, mathematics, or biostatistics is the most direct route, though many people enter from biology with strong quantitative coursework. A master's degree in biostatistics is the standard entry credential for industry and academic collaboration. A master of public health with a biostatistics concentration serves the same purpose for public health careers. A doctorate is usual for methodological research, for leading academic groups, and for senior roles where the person is expected to invent methods rather than apply them.

Coursework that employers expect includes probability, mathematical statistics, linear models, categorical data analysis, survival analysis, clinical trials design, statistical computing, and epidemiology. Programming skill in R and SAS is close to mandatory in clinical research, with Python increasingly common in genomics and data science roles and SQL needed for record-based work. Professional statistical associations offer accreditation programs, but no license is required to practice biostatistics in the United States.

### Skills that separate strong candidates

Biological literacy is the most underrated. A statistician who understands what a CD4 count, an ejection fraction, or a minimal residual disease measurement means will ask better questions than one who treats every column as an abstract variable.

Other differentiators are clear writing, comfort with ambiguity, the ability to explain a method to a non-statistician without condescension, and disciplined documentation. Regulatory literacy, meaning familiarity with good clinical practice and the structure of a submission, is valuable in industry. Reproducible programming habits are valuable everywhere.

### Adjacent roles

Statistical programmers build and validate the code that produces tables and figures, a distinct role from biostatistician in many organizations. Data managers design the case report forms and clean the raw data. Bioinformaticians build molecular pipelines. Epidemiologists design and interpret population studies. Health outcomes researchers apply these methods to real-world evidence. Clinical data scientists do similar work with a machine learning emphasis. All of these roles overlap with biostatistics, and movement between them is common.

Compensation varies substantially by sector, degree level, and geography. Industry and regulatory-adjacent roles generally sit above academic ones, and doctoral-level statisticians with submission experience command the highest packages. Entry-level hiring usually tests programming competence and basic inference, while senior hiring tests judgment about design.

## Common Mistakes and Limitations

**Reading a p-value as an effect size.** A huge trial can make a trivial difference statistically significant. Always read the estimate and the interval together.

**Treating [statistical significance](/blog/guides/statistical-significance) as clinical significance.** A 0.1 mmHg blood pressure reduction can be significant and still be useless to a patient.

**Ignoring multiplicity.** Testing many endpoints or subgroups without correction manufactures findings. Pre-specification is the best defense, and formal correction is the fallback.

**Swapping standard deviation and standard error.** They answer different questions, and presenting the smaller one without a label misleads readers.

**Misreading confidence intervals.** The 95% refers to the procedure's long-run coverage, not the probability that a given interval contains the truth.

**Confusing association with causation.** Observational estimates always carry the possibility of unmeasured confounding. Adjustment handles measured confounders only, and mismeasured confounders remain problematic even after adjustment.

**Neglecting the base rate.** As the screening example shows, a good test in a low-prevalence population can produce mostly false positives.

**Post hoc subgroup stories.** A dramatic effect in one site, sex, or age band, discovered after unblinding, is usually noise. Subgroup analyses are credible when pre-specified, biologically motivated, and tested for interaction.

**Overfitting.** Too many predictors for too few events produces a model that fits the past and fails the future.

**Immortal time bias.** Classifying patients by a treatment they received later in follow-up gives that group guaranteed survival time before treatment began. The fix is to define exposure at a fixed landmark and analyze from there.

**Assuming software output equals a valid analysis.** Software will happily fit a model whose assumptions are violated. Diagnostics are not optional.

### Limitations of the discipline itself

Biostatistics quantifies uncertainty conditional on a model. If the model is wrong, the uncertainty statement is wrong, and no amount of computation fixes it. Observational data cannot fully rule out unmeasured confounding. Randomized trials answer narrow questions in selected populations, and extrapolating a trial result to a patient excluded from it is a clinical judgment, not a statistical one. Missing data methods rest on assumptions about why data are missing, and those assumptions are usually untestable. Individual patient decisions require a clinician who knows the person, not only the estimate.

## Quick Review

1. Biostatistics is the design, analysis, and interpretation of data from biology, medicine, and public health, with uncertainty reported as a matter of course.
2. Its methods follow a sequence: question, design, variable classification, sample size, data organization, description, inference, modeling, assumption checks, reporting.
3. Biostatistics differs from general statistics mainly in its constraints: ethical limits on randomization, dropout and censoring, measurement error, and regulatory review.
4. A confidence interval describes plausible effect sizes. A p-value describes how surprising the data are under a null model. Neither substitutes for the other.
5. Power and sample size are decided before data collection, and effect size drives the requirement quadratically.
6. In public health, age standardization, incidence and prevalence, epidemic models, and predictive values are everyday tools [4][3].
7. A biostatistician's job is roughly one third design, one third analysis and programming, and one third communication.

## Frequently Asked Questions

### What is biostatistics in simple terms?

Biostatistics is statistics applied to living things, focused on designing studies, estimating effects, and stating how uncertain those estimates are. It answers questions like whether a treatment works, how common a disease is, and whether a test result can be trusted.

### What is the difference between biostatistics and statistics?

The mathematics is shared. Biostatistics applies it to biological and medical problems, where ethical limits on experimentation, missing data, measurement error, and regulatory requirements shape which methods are acceptable.

### What are examples of biostatistics in public health?

Common examples include age-standardized disease rates from surveillance systems, vaccine efficacy calculated from trial risk ratios, outbreak projections from compartmental models, and positive predictive value calculations used to evaluate screening programs [4].

### What methods do biostatisticians use?

The core set includes descriptive statistics, confidence intervals, hypothesis tests, linear and logistic regression, survival analysis, diagnostic accuracy analysis, and meta-analysis. Modern practice adds Bayesian methods, machine learning, and reproducible statistical programming [5].

### What does a biostatistician do all day?

The work splits between designing studies and calculating sample sizes, writing and validating analysis code, interpreting output with clinical teams, and documenting results for regulators, journals, or program managers. Writing and explaining take up more time than most outsiders expect.

### Do you need a PhD to become a biostatistician?

No. A master's degree in biostatistics or a related quantitative field is the standard entry credential for industry, contract research, and academic collaboration. A doctorate is typical for methodological research and senior academic or strategic roles.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is biostatistics in simple terms?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Biostatistics is statistics applied to living things, focused on designing studies, estimating effects, and stating how uncertain those estimates are. It answers questions like whether a treatment works, how common a disease is, and whether a test result can be trusted."
      }
    },
    {
      "@type": "Question",
      "name": "What is the difference between biostatistics and statistics?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The mathematics is shared. Biostatistics applies it to biological and medical problems, where ethical limits on experimentation, missing data, measurement error, and regulatory requirements shape which methods are acceptable."
      }
    },
    {
      "@type": "Question",
      "name": "What are examples of biostatistics in public health?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Common examples include age-standardized disease rates from surveillance systems, vaccine efficacy calculated from trial risk ratios, outbreak projections from compartmental models, and positive predictive value calculations used to evaluate screening programs."
      }
    },
    {
      "@type": "Question",
      "name": "What methods do biostatisticians use?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The core set includes descriptive statistics, confidence intervals, hypothesis tests, linear and logistic regression, survival analysis, diagnostic accuracy analysis, and meta-analysis. Modern practice adds Bayesian methods, machine learning, and reproducible statistical programming."
      }
    },
    {
      "@type": "Question",
      "name": "What does a biostatistician do all day?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The work splits between designing studies and calculating sample sizes, writing and validating analysis code, interpreting output with clinical teams, and documenting results for regulators, journals, or program managers. Writing and explaining take up more time than most outsiders expect."
      }
    },
    {
      "@type": "Question",
      "name": "Do you need a PhD to become a biostatistician?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. A master's degree in biostatistics or a related quantitative field is the standard entry credential for industry, contract research, and academic collaboration. A doctorate is typical for methodological research and senior academic or strategic roles."
      }
    }
  ]
}
</script>

## Further Reading

- [[Chinese medicine as vegetative systems biology. Part I: therapeutic methods].](https://pubmed.ncbi.nlm.nih.gov/22159335/)

## Sources

1. [Biostatistics for Evidence-Based Medicine: A Practical Review for Clinicians](https://pubmed.ncbi.nlm.nih.gov/42893547/)
2. [In Silico Methods for Studying T Cell Biology.](https://pubmed.ncbi.nlm.nih.gov/30635092/)
3. [A Global Overview of Precision Medicine in Type 2 Diabetes](https://pubmed.ncbi.nlm.nih.gov/30237159/)
4. [Mathematical modeling and intelligent methods in systems biology and medicine applied to complex diseases: An overview.](https://pubmed.ncbi.nlm.nih.gov/42833389/)
5. [Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine](https://pubmed.ncbi.nlm.nih.gov/34245839/)

## Related Articles

- [What Is Hypothesis Testing? Steps, Errors and Examples](/blog/data-analysis/what-is-hypothesis-testing)
- [Incidence vs Prevalence: Definitions, Formulas and Worked Examples](/blog/data-analysis/incidence-vs-prevalence)
- [Positive and Negative Predictive Value: Formula, Examples and Why Prevalence Matters](/blog/data-analysis/positive-predictive-value)
- [Principal Component Analysis (PCA) Explained Simply, With a Worked Example](/blog/data-analysis/principal-component-analysis-explained)
- [R vs Python: Differences and When to Use Each](/blog/data-analysis/r-vs-python-data-analysis)